Skip to content

Variant™ Hemoglobin a 1C Program

by Bio-Rad

510(k) K926469

Variant Hemoglobin a 1C Program is a medical device (FDA Class II; FDA product code LCP, Assay, Glycosylated Hemoglobin) made by Bio-Rad, cleared under FDA 510(k) K926469 on 29 Mar 1993, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK926469 Date29 Mar 1993ClearedStatusActive

Official records

From the FDA record

Received by the FDA
28 Dec 1992
FDA decision
29 Mar 1993 (Substantially Equivalent)
FDA review time
91 days from receipt to decision
Public document
510(k) statement on file with the FDA

From the FDA 510(k) record K926469 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Variant(Tm) Hemoglobin a 1C Program
510(k) Number
FDA product code
LCP
Device class
Class II
Regulation
21 CFR Part 864.7470
Advisory committee
Hematology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code LCP (Assay, Glycosylated Hemoglobin).

Other devices from Bio-Rad

See all devices from Bio-Rad →